See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
News, Data, Transcripts
Haemonetics Corp. (HAE)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: HAE
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Forbes' 200 Best Small Companies Through the Magic Formula Screen
MagicDiligence
•
Dec 02
•
5 Comments
Small Laggards: Suggestions for Chasing the Market
Alan Brochstein
•
Sep 24
•
3 Comments
Why I Swapped Haemonetics for Oshkosh
Robert Freedland
•
Aug 05
•
4 Comments
ETF Trends: Economic News Lifts Primary Trend for Stocks
J Clinton Hill
•
Aug 04
•
Comment!
15 Possible Healthcare Breakout Stocks
Marco Hickey
•
Jun 21
•
9 Comments
Latest Trend Leaders
Trade Radar Operator
•
May 15
•
2 Comments
More articles on HAE »
Latest Transcript
Haemonetics Corporation F3Q09 Earnings Call Transcript
Mon February 2, 2009
More transcripts on HAE »
Instablogs
Top 5 Stocks > How to Pick Good Stocks to Trade Now
Mon February 8, 2010
•
stocks to Invest in
•
Comment!
Healthcare Stock Watch: My Short List of Booming (and Busting) Companies
Wed January 20, 2010
•
Marc Lichtenfeld
•
1 Comment
15 Possible Healthcare Breakout Stocks for the Watch List
Sat June 20, 2009
•
Marco Hickey
•
Comment!
Write a post on HAE
|
More Instablogs on HAE »
Sentiment
What advice would you give to
HAE?
124 characters left
What's your view of HAE?
Make sure you include HAE
140 characters left
|
Settings
Mike Havrilla
: $
DYAX
/ Dyax Corp. +10%
AH
/ Receives FDA Approval for Kalbitor (ecallantide) for acute atacks
HAE
/
http://bit.ly/51ZSaH
Tue, Dec 01, 2009
Mike Havrilla
: $
DYAX
<> Dyax Corp. <> FDA decision expected 1-Dec <> Kalbitor (
DX
-88) for treatment of acute attacks of hereditary angioedema (
HAE
)
Mon, Nov 30, 2009
More StockTalks on HAE »